{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:38:07Z","timestamp":1782362287856,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jdcr.2019.09.026","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T19:28:05Z","timestamp":1574450885000},"page":"1084-1087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dermatomyositis recalcitrant to treatment associated with occult malignancy"],"prefix":"10.1016","volume":"5","author":[{"given":"Jennifer","family":"Kane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Bowerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar A.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2019.09.026_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7326\/0003-4819-84-1-68","article-title":"Dermatomyositis and malignancy. A review of the literature","volume":"84","author":"Barnes","year":"1976","journal-title":"Ann Intern Med"},{"issue":"9250","key":"10.1016\/j.jdcr.2019.09.026_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jdcr.2019.09.026_bib3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jaad.2018.11.023","article-title":"Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis","volume":"80","author":"Hoesly","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2019.09.026_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottich population-based cohort study","volume":"85","author":"Stockton","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jdcr.2019.09.026_bib5","doi-asserted-by":"crossref","first-page":"e94128","DOI":"10.1371\/journal.pone.0094128","article-title":"Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis","volume":"9","author":"Lu","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jdcr.2019.09.026_bib6","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jdcr.2019.09.026_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0b013e31819da352","article-title":"Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis","volume":"88","author":"Fardet","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.jdcr.2019.09.026_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2019.09.026_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0190-9622(82)70018-0","article-title":"The value of malignancy evaluation in patients with dermatomyositis","volume":"6","author":"Callen","year":"1982","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2019.09.026_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archderm.1990.01670250067010","article-title":"Dermatomyositis. Disease associations and an evaluation of screening investigations for malignancy","volume":"126","author":"Cox","year":"1990","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.jdcr.2019.09.026_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/oxfordjournals.annonc.a059281","article-title":"Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The kiel lymphoma study group","volume":"6","author":"Siegert","year":"1995","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.jdcr.2019.09.026_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/1346-8138.13299","article-title":"Angioimmunoblastic T cell lymphoma mimicking dermatomyositis","volume":"43","author":"Saito","year":"2016","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2019.09.026_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamadermatol.2017.3758","article-title":"Factors associated with clinical remission of skin disease in dermatomyositis","volume":"154","author":"Wolstencroft","year":"2018","journal-title":"JAMA Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251261930623X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251261930623X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:20:50Z","timestamp":1762474850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251261930623X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S235251261930623X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.09.026","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatomyositis recalcitrant to treatment associated with occult malignancy","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}